Akeso's immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening Chinese drug ...

Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...

Operator: Good afternoon, and welcome to the Evoke Pharma, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call. Currently, all callers have been placed in a listen-only mode.

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

Staff and funding cuts to the NIH, FDA and USAID could have downstream implications for R&D in the pharma industry, experts ...

Research shows how specific natural nootropics can enhance memory, focus, and cognitive processing while potentially offering ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

CDMOs and CROs share their most recent business highlights from the past twelve months on the oral solid dosage front.

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...

Montgomery County’s SFA Therapeutics — led by the scientist behind Effexor and Rapamune — is in it for the long haul, with promising results.

Insilico Medicine, whose Hong Kong IPO application lapsed in 2024, is still considering going public in the city, said ...